Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluation of a new device for spinal fusion in patients with lumbar degeneration

Official title: Clinical/Radiological Outcomes Associated With CONDUIT™ Anterior Lumbar Interbody Fusion (ALIF) Cage System With Supplemental Fixation for Treatment of Lumbar Degenerative Disc Disease at One or Two Contiguous Spinal Levels From L2-S1

Run by University College Dublin · NCT06940453 · Data updated 2026-11-12

This study is testing a new 3D printed titanium device for spinal fusion in patients with lower back problems to see how well it works compared to older options.

More Degenerative Disc Disease Lumbar trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment35 (estimated)
SponsorUniversity College Dublin
Academic / other
Locations1 site (Dublin, Leinster)
StatusRecruiting
StartedJune 28, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedApril 23, 2025
Trial IDNCT06940453 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are undergoing anterior lumbar interbody fusion and are suitable for the CONDUIT cage system.

Probably not a fit

Patients under 18, those with contraindications to surgery, or those with established osteoporosis or systemic diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will follow patients undergoing anterior lumbar interbody fusion (ALIF) using the CONDUIT™ ALIF Cage System at a National Tertiary Referral Centre. The study aims to evaluate the performance of this CE-marked device, which is a 3D printed titanium implant designed to facilitate spinal fusion. It will assess outcomes in both frail and non-frail patient cohorts, comparing results to historical cases using SYNFIX Systems. The study will include patients aged 18 and older who are appropriate candidates for the ALIF procedure.

Why it matters

Potential benefit: If successful, this study could improve surgical outcomes for patients with lumbar degenerative disease by providing a more effective spinal fusion device.

How similar studies have gone: Other studies have shown success with similar spinal fusion devices, but the specific use of the CONDUIT™ ALIF Cage System is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged ≥ 18 years old
* Consenting patients undergoing anterior lumbar interbody fusion (ALIF) procedure whom the Conduit cage system is appropriate will be included in this study.

Exclusion Criteria:

* Patients under 18 years of age
* Non-surgical candidates, patients with contraindications to surgery (e.g. medical comorbidities, known infection, pregnancy etc.),
* Patients with established osteoporosis
* Long-term, systemic steroid use
* Systemic diseases (e.g. rheumatoid arthritis, AIDS, HIV, etc.),
* Patients unwilling or unable to give informed consent, or patients unwilling or unable to complete Health-related quality of (HRQOL) outcome life measures at the specified study time points pre- and post-operatively.
* Subjects who have a history of drug or alcohol use that, in the opinion of the investigator, would interfere with adherence to study requirements.

Where it's running

  • Mater Misericordiae University Hospital
    Dublin, Leinster, Ireland
    Recruiting

Study contacts

  • Principal investigator: Joseph Butler, PhD — Mater Misericordiae University Hospital
  • Study coordinator: Jake McDonnell, MRCS
  • Email: jakemcdonnell@eril.ie
  • Phone: +353852802958

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.